However, they also reported that T393C polymorphism in the gene GNAS1 was significantly associated with favorable clinical outcome of patients suffering from bladder cancer, chronic lymphocytic leukemia [15], and renal cell carcinoma [16]. This evidence concerns the gene GNAS and urinary bladder cancer.